Skip to content
Screener

Alkermes ALKS Current Debt

Current Debt at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$1.03B-78.2%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$1.03B+3,224%
AbbVie logo
AbbVieABBV
$0-100%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$70M
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$0-100%
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
$20M+14.3%

Other financials

Income statement

See full
Revenue$496.0M+27.0%
Gross profit$397.9M+16.6%
Operating income$18.4M-80.3%
Net income$501.0K-99.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$511.5M-1.9%
Total debt$1.6B+2,064%
Total equity$1.8B+11.3%
Total assets$4.4B+95.0%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$8.1M-37.4%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$8.32B+89.9%
Enterprise value$9.38B+139%
P/E125.9×+113×
P/S+2.1×

Profitability

See full
Gross margin84.6%-0.6pp
Operating margin7%-17.8pp
Net margin4%-19.2pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity3.9%-20.1pp
Debt / equity0.9×+0.8×
Current ratio2.3×-0.9×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The source filing: Alkermes’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 9:22 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-319022
Line itemJune 30, 2026December 31, 2025
Accounts payable and accrued expenses$332,469$289,565
Accrued sales discounts, allowances and reserves295,645247,126
Operating lease liabilities—short-term7,4776,746
Current portion of long-term debt26,500
Total current liabilities662,091543,437
OPERATING LEASE LIABILITIES—LONG-TERM61,97663,253
CONTINGENT CONSIDERATION136,304
LONG-TERM DEBT1,476,611

Item 1. Condensed Consolidated Financial Statements:

FAQ

What is Alkermes's current debt?
Alkermes (ALKS) reported current debt of $26.5M in Q2 2026.
What is the long-term trend for Alkermes's current debt?
Over 4 years (2020 to 2025), Alkermes's current debt has grown at a -100.0% compound annual growth rate (CAGR), from $2.84M to $0.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Ask your AI about Alkermes's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude